ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Valencia, VC, ESP:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Valencia, Spain and 59 other locations

States, where 2 out of 3 non-traumatic amputations derive from diabetes. This is why the main objective of this project is to establish a st...

Invitation-only
Diabetic Foot
Other: Orthopedic intervention
University of Valencia

Valencia, Spain

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Valencia, Spain and 78 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 227 other locations

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes...

Begins enrollment in 2 months
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

Phase 3

Lilly
Lilly

Valencia, Spain and 128 other locations

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Valencia, Spain and 46 other locations

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Chronic Kidney Disease
Drug: Orforglipron
Drug: Insulin Glargine

Phase 3

Lilly
Lilly

Alzira, Valencia, Spain and 370 other locations

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high ...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Valencia, Spain and 88 other locations

will be done in participants who have type 2 diabetes. Participants will take the study medicine together with the current diabetes...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Placebo semaglutide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 400 other locations

in comparison with the active control, ranibizumab, in patients with diabetic macular edema (DME)In the first year, all 3 treatment groups w...

Active, not recruiting
Diabetic Macular Edema (DME)
Drug: EYE103
Drug: Ranibizumab

Phase 2, Phase 3

EyeBiotech

Burjassot, Valencia, Spain and 182 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems